The Big Picture: Dr. Puja Uppal, Family Medicine, “The news about GLP-1 RA medicines keeps getting better by the day.”
Doctor’s Expert Insights About GLP-1 RAs for Colorectal Cancer in Georgia
Know this: “Wow, this is another blockbuster finding to add to the positive effects of GLP-1 medications. Researchers from Case Western Reserve University are revealing a potential breakthrough–a diabetes drug may significantly lower colorectal cancer risk. The study underscores the importance of exploring existing medications for new therapeutic purposes. It’s a promising step forward in the fight against one of the more dangerous forms of cancer. GLP-1 RA are medicines like Ozempic, Semaglutide, Trulicity, and others. Also, make sure you’re talking to your healthcare team and know your A1c blood values ” Dr. Adriana Davis, Family Medicine.
Beyond the news: This discovery could pave the way for more effective prevention strategies to potentially reduce the overall incidence and mortality rates of colorectal cancer.
Macon Focus: Watch a Short Video about the New Diabetes Medicine–Mounjaro (Tirzepatide).
Health Alert for Macon
Key Drivers in Bibb County:
The study found that patients who took GLP-1 RAs had a 44% reduction in the risk of colorectal cancer compared to those who took insulin, and a 25% reduction compared to those who took metformin.
The research involved analyzing over 1.2 million patient records and comparing colorectal cancer incidence among those treated with different anti-diabetic medications.
Keep in mind, that this is preliminary. More research is needed, including clinical trials. The good news here is that these results suggest that GLP-1 RAs may be a promising way to prevent colorectal cancer in patients with diabetes.
“The research is critically important for reducing incidence of CRC in patients with diabetes, with or…
Read the full article here